Regulation of Rab5 Function during Phagocytosis of Live Pseudomonas aeruginosa in Macrophages

Infection and Immunity

Volumn 81, Issue 7, 2013, Pages 2426-2436

  Mustafi, Sushmita ^a   Rivero, Nathalie ^b   Olson, Joan C ^b   Stahl, Philip D ^c   Barbieri, M Alejandro ^a,d  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FAIRCHILD TROPICAL BOTANIC GARDEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RIN1; PSEUDOMONAS EXOTOXIN; RAB PROTEIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CONTROLLED STUDY; DEFENSE MECHANISM; GENE EXPRESSION SYSTEM; HYDROLYSIS; IN VITRO STUDY; INTERNALIZATION; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RNA INTERFERENCE; SURVIVAL RATE; TYPE III SECRETION SYSTEM;

ADP RIBOSE TRANSFERASES; ANIMALS; BACTERIAL TOXINS; CELL LINE; ENZYME ACTIVATION; EXOTOXINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GREEN FLUORESCENT PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MACROPHAGES; MICE; PHAGOCYTOSIS; PROTEOLYSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RAB GTP-BINDING PROTEINS; RAB5 GTP-BINDING PROTEINS; RNA INTERFERENCE;

EID: 84879453471     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00387-13     Document Type: Article

References (55)

1. Domingo P, Ferre A, Baraldes MA, Ris J, Sanchez F. 1998. Pseudomonas aeruginosa bronchopulmonary infection in patients with AIDS, with emphasis on relapsing infection. Eur. Respir. J. 12:107-112.
2. Maschmeyer G, Braveny I. 2000. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur. J. Clin. Microbiol. Infect. Dis. 19:915-925.
3. Mendelson MH, Gurtman A, Szabo S, Neibart E, Meyers BR, Policar M, Cheung TW, Lillienfeld D, Hammer G, Reddy S, Choi K, Hirschman SZ. 1994. Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin. Infect. Dis. 18:886-895.
4. Pruitt BA, Jr. 1974. Infections caused by Pseudomonas species in patients with burns and in other surgical patients. J. Infect. Dis. 130(Suppl.):S8-S13.
5. Hauser AR. 2009. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7:654-665.
6. Hueck CJ. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:379-433.
7. Soong G, Parker D, Magargee M, Prince AS. 2008. The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function. J. Bacteriol. 190:2814-2821.
8. Lyczak JB, Cannon CL, Pier GB. 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2:1051-1060.
9. Barbieri JT, Sun J. 2004. Pseudomonas aeruginosa ExoS and ExoT. Rev. Physiol. Biochem. Pharmacol. 152:79-92.
10. Frithz-Lindsten E, Du Y, Rosqvist R, Forsberg A. 1997. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type IIIdependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol. Microbiol. 25:1125-1139.
11. Goehring UM, Schmidt G, Pederson KJ, Aktories K, Barbieri JT. 1999. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J. Biol. Chem. 274:36369-36372.
12. Krall R, Schmidt G, Aktories K, Barbieri JT. 2000. Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect. Immun. 68:6066-6068.
13. Cowell BA, Chen DY, Frank DW, Vallis AJ, Fleiszig SM. 2000. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells. Infect. Immun. 68:403-406.
14. Rocha CL, Coburn J, Rucks EA, Olson JC. 2003. Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A. 1 macrophages. Infect. Immun. 71:5296-5305.
15. Deng Q, Barbieri JT. 2008. Modulation of host cell endocytosis by the type III cytotoxin, Pseudomonas ExoS. Traffic 9:1948-1957.
16. McGuffie EM, Frank DW, Vincent TS, Olson JC. 1998. Modification of Ras in eukaryotic cells by Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 66:2607-2613.
17. Fraylick JE, Riese MJ, Vincent TS, Barbieri JT, Olson JT. 2002. ADPribosylation and functional effects of Pseudomonas exoenzyme S on cellular RalA. Biochemistry 41:9680-9687.
18. Henriksson ML, Sundin C, Jansson AL, Forsberg A, Palmer RH, Hallberg B. 2002. Exoenzyme S shows selective ADP-ribosylation and GTPaseactivating protein (GAP) activities towards small GTPases in vivo. Biochem. J. 367:617-628.
19. Liu S, Yahr TL, Frank DW, Barbieri JT. 1997. Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa. J. Bacteriol. 179:1609-1613.
20. Sun J, Barbieri JT. 2003. Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins. J. Biol. Chem. 278:32794-32800.
21. Deng Q, Sun J, Barbieri JT. 2005. Uncoupling Crk signal transduction by Pseudomonas exoenzyme T. J. Biol. Chem. 280:35953-35960.
22. Sato H, Frank DW, Hillard CJ, Feix JB, Pankhaniya RR, Moriyama KK, Finck-Barbancon V, Buchaklian A, Lei M, Long RM, Wiener-Kronish J, Sawa T. 2003. The mechanism of action of the Pseudomonas aeruginosaencoded type III cytotoxin, ExoU. EMBO J. 22:2959-2969.
23. Diaz MH, Shaver CM, King JD, Musunuri S, Kazzaz JA, Hauser AR. 2008. Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect. Immun. 76:4414-4421.
24. Vance RE, Rietsch A, Mekalanos JJ. 2005. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect. Immun. 73:1706-1713.
25. Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW. 1998. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. U. S. A. 95:13899-13904.
26. Fraylick JE, Rucks EA, Greene DM, Vincent TS, Olson JC. 2002. Eukaryotic cell determination of ExoS ADP-ribosyltransferase substrate specificity. Biochem. Biophys. Res. Commun. 291:91-100.
27. Mukherjee K, Parashuraman S, Raje M, Mukhopadhyay A. 2001. SopE acts as an Rab5-specific nucleotide exchange factor and recruits nonprenylated Rab5 on Salmonella-containing phagosomes to promote fusion with early endosomes. J. Biol. Chem. 276:23607-23615.
28. Madan R, Krishnamurthy G, Mukhopadhyay A. 2008. SopE-mediated recruitment of host Rab5 on phagosomes inhibits Salmonella transport to lysosomes. Methods Mol. Biol. 445:417-437.
29. Mallo GV, Espina M, Smith AC, Terebiznik MR, Aleman A, Finlay BB, Rameh LE, Grinstein S, Brumell JH. 2008. SopB promotes phosphatidylinositol 3-phosphate formation on Salmonella vacuoles by recruiting Rab5 and Vps34. J. Cell Biol. 182:741-752.
30. Clemens DL, Lee BY, Horwitz MA. 2000. Deviant expression of Rab5 on phagosomes containing the intracellular pathogens Mycobacterium tuberculosis and Legionella pneumophila is associated with altered phagosomal fate. Infect. Immun. 68:2671-2684.
31. Alvarez-Dominguez C, Barbieri MA, Beron W, Wandinger-Ness A, Stahl PD. 1996. Phagocytosed live Listeria monocytogenes influences Rab5-regulated in vitro phagosome-endosome fusion. J. Biol. Chem. 271: 13834-13843.
32. Duclos S, Diez R, Garin J, Papadopoulou B, Descoteaux A, Stenmark H, Desjardins M. 2000. Rab5 regulates the kiss and run fusion between phagosomes and endosomes and the acquisition of phagosome leishmanicidal properties in RAW 264.7 macrophages. J. Cell Sci. 19:3531-3541.
33. Olchowik M, Miaczynska M. 2009. Effectors of GTPase Rab5 in endocytosis and signal transduction. Postepy Biochem. 55:171-180.
34. Hunker CM, Galvis A, Kruk I, Giambini H, Veisaga ML, Barbieri MA. 2006. Rab5-activating protein 6, a novel endosomal protein with a role in endocytosis. Biochem. Biophys. Res. Commun. 340:967-975.
35. Haas AK, Fuchs E, Kopajtich A, Barr F. 2005. A GTPase-activating protein controls Rab5 function in endocytic trafficking. Nat. Cell Biol. 7:887-893.
36. Goh T, Uchida W, Arakawa S, Ito E, Dainobu T, Ebine K, Takeuchi M, Sato K, Ueda T, Nakano A. 2007. VPS9a, the common activator for two distinct types of Rab5 GTPases, is essential for the development of Arabidopsis thaliana. Plant Cell 19:3504-3515.
37. Stenmark H, Parton RG, Steele-Mortimer O, Lutcke A, Gruenberg Zerial JM. 1994. Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J. 13:1287-1296.
38. Nakaya M, Tanaka M, Okabe Y, Hanayama R, Nagata S. 2006. Opposite effects of rho family GTPases on engulfment of apoptotic cells by macrophages. J. Biol. Chem. 28:8836-8842.
39. Diment S, Leech MS, Stahl PD. 1987. Generation of macrophage variants with 5-azacytidine: selection for mannose receptor expression. J. Leukoc. Biol. 42:485-490.
40. Bridge DR, Martin KM, Moore ER, Lee VM, Carroll JA, Rocha CL, Olson JC. 2012. Examining the role of actin-plasma membrane association in Pseudomonas aeruginosa infection and type III secretion translocation in migratory T24 epithelial cells. Infect. Immun. 80:3049-3064.
41. Barbieri MA, Fernandez-Pol S, Hunker C, Horazdovsky BH, Stahl PD. 2004. Role of rab5 in EGF receptor-mediated signal transduction. Eur. J. Cell Biol. 83:305-314.
42. Goldova J, Ulrych A, Hercik K, Branny P. 2011. A eukaryotic-type signalling system of Pseudomonas aeruginosa contributes to oxidative stress resistance, intracellular survival and virulence. BMC Genomics 12: 437.
43. Angus AA, Evans DJ, Barbieri JT, Fleiszig SM. 2010. The ADPribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells. Infect. Immun. 78:4500-4510.
44. Brumell JH, Scidmore MA. 2007. Manipulation of rab GTPase function by intracellular bacterial pathogens. Microbiol. Mol. Biol. Rev. 71:636-652.
45. Barbieri AM, Sha Q, Bette-Bobillo P, Stahl PD, Vidal M. 2001. ADPribosylation of Rab5 by ExoS of Pseudomonas aeruginosa affects endocytosis. Infect. Immun. 69: 5329-5334.
46. Fleiszig SM, Wiener-Kronish JP, Miyazaki H, Vallas V, Mostov KE, Kanada D, Sawa T, Yen TS, Frank DW. 1997. Pseudomonas aeruginosamediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect. Immun. 65:579-586.
47. Garrity-Ryan L, Shafikhani SS, Balachandran PP, Nguyen LL, Oza JJ, Jakobsen TT, Sargent J, Fang X, Cordwell S, Matthay MA, Engel JN. 2004. The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities. Infect. Immun. 72:546-558.
48. Wretlind B, Pavlovskis OR. 1983. Pseudomonas aeruginosa elastase and its role in pseudomonas infections. Rev. Infect. Dis. 5(Suppl.):S998-S1004.
49. Ruhen RW, Holt PG, Papadimitriou JM. 1980. Antiphagocytic effect of Pseudomonas aeruginosa exopolysaccharide. J. Clin. Pathol. 33:1221-1222.
50. Pavlovskis OR, Pollack M, Callahan LT, 3rd, Iglewski BH. 1977. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections. Infect. Immun. 18:596-602.
51. Hauser AR, Fleiszig S, Kang PJ, Mostov K, Engel JN. 1998. Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells. Infect. Immun. 66:1413-1420.
52. Krall R, Sun J, Pederson KJ, Barbieri JT. 2002. In vivo rho GTPaseactivating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect. Immun. 70:360-367.
53. Rucks EA, Fraylick JE, Brandt LM, Vincent TS, Olson JC. 2003. Cell line differences in bacterially translocated ExoS ADP-ribosyltransferase substrate specificity. Microbiology 149:319-331.
54. Valencia A, Chardin P, Wittinghofer A, Sander C. 1991. The ras protein family: evolutionary tree and role of conserved amino acids. Biochemistry 30:4637-4648.
55. Li G, Stahl PD. 1993. Structure-function relationship of the small GTPase rab5. J. Biol. Chem. 268:24475-24480.